231 related articles for article (PubMed ID: 35659320)
1. Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis.
Xie Y; Wang B; Zhao Y; Tao Z; Wang Y; Chen G; Hu X
J Hematol Oncol; 2022 Jun; 15(1):72. PubMed ID: 35659320
[TBL] [Abstract][Full Text] [Related]
2. Glycyrrhetinic acid induces oxidative/nitrative stress and drives ferroptosis through activating NADPH oxidases and iNOS, and depriving glutathione in triple-negative breast cancer cells.
Wen Y; Chen H; Zhang L; Wu M; Zhang F; Yang D; Shen J; Chen J
Free Radic Biol Med; 2021 Sep; 173():41-51. PubMed ID: 34271106
[TBL] [Abstract][Full Text] [Related]
3. Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer.
Zhang Z; Lu M; Chen C; Tong X; Li Y; Yang K; Lv H; Xu J; Qin L
Theranostics; 2021; 11(7):3167-3182. PubMed ID: 33537080
[No Abstract] [Full Text] [Related]
4. Simvastatin induced ferroptosis for triple-negative breast cancer therapy.
Yao X; Xie R; Cao Y; Tang J; Men Y; Peng H; Yang W
J Nanobiotechnology; 2021 Oct; 19(1):311. PubMed ID: 34627266
[TBL] [Abstract][Full Text] [Related]
5. Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple-negative breast cancer cells.
Du J; Wang L; Huang X; Zhang N; Long Z; Yang Y; Zhong F; Zheng B; Lan W; Lin W; Ma W
Phytomedicine; 2021 May; 85():153551. PubMed ID: 33827043
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer.
Wang Y; Sun Y; Wang F; Wang H; Hu J
Biomed Pharmacother; 2023 Dec; 169():115866. PubMed ID: 37951026
[TBL] [Abstract][Full Text] [Related]
7. ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma.
Klasson TD; LaGory EL; Zhao H; Huynh SK; Papandreou I; Moon EJ; Giaccia AJ
Cancer Metab; 2022 Oct; 10(1):14. PubMed ID: 36192773
[TBL] [Abstract][Full Text] [Related]
8. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells.
Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q
J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669
[TBL] [Abstract][Full Text] [Related]
9. ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro.
Schmid R; Wolf K; Robering JW; Strauß S; Strissel PL; Strick R; Rübner M; Fasching PA; Horch RE; Kremer AE; Boos AM; Weigand A
BMC Cancer; 2018 Dec; 18(1):1273. PubMed ID: 30567518
[TBL] [Abstract][Full Text] [Related]
10. Ferroptosis: the emerging player in remodeling triple-negative breast cancer.
Li J; He D; Li S; Xiao J; Zhu Z
Front Immunol; 2023; 14():1284057. PubMed ID: 37928550
[TBL] [Abstract][Full Text] [Related]
11. The paracrine effects of adipocytes on lipid metabolism in doxorubicin-treated triple negative breast cancer cells.
Mentoor I; Engelbrecht AM; van de Vyver M; van Jaarsveld PJ; Nell T
Adipocyte; 2021 Dec; 10(1):505-523. PubMed ID: 34812105
[TBL] [Abstract][Full Text] [Related]
12. HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk.
Li H; Yang P; Wang J; Zhang J; Ma Q; Jiang Y; Wu Y; Han T; Xiang D
J Hematol Oncol; 2022 Jan; 15(1):2. PubMed ID: 34991659
[TBL] [Abstract][Full Text] [Related]
13. Adipose microenvironment promotes triple negative breast cancer cell invasiveness and dissemination by producing CCL5.
D'Esposito V; Liguoro D; Ambrosio MR; Collina F; Cantile M; Spinelli R; Raciti GA; Miele C; Valentino R; Campiglia P; De Laurentiis M; Di Bonito M; Botti G; Franco R; Beguinot F; Formisano P
Oncotarget; 2016 Apr; 7(17):24495-509. PubMed ID: 27027351
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis: a promising target for cancer immunotherapy.
Sun LL; Linghu DL; Hung MC
Am J Cancer Res; 2021; 11(12):5856-5863. PubMed ID: 35018229
[TBL] [Abstract][Full Text] [Related]
15. Adipocytes induce distinct gene expression profiles in mammary tumor cells and enhance inflammatory signaling in invasive breast cancer cells.
Nickel A; Blücher C; Kadri OA; Schwagarus N; Müller S; Schaab M; Thiery J; Burkhardt R; Stadler SC
Sci Rep; 2018 Jun; 8(1):9482. PubMed ID: 29930291
[TBL] [Abstract][Full Text] [Related]
16. Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells.
Yu M; Gai C; Li Z; Ding D; Zheng J; Zhang W; Lv S; Li W
Cancer Sci; 2019 Oct; 110(10):3173-3182. PubMed ID: 31464035
[TBL] [Abstract][Full Text] [Related]
17. Activation of MAT2A-ACSL3 pathway protects cells from ferroptosis in gastric cancer.
Ma M; Kong P; Huang Y; Wang J; Liu X; Hu Y; Chen X; Du C; Yang H
Free Radic Biol Med; 2022 Mar; 181():288-299. PubMed ID: 35182729
[TBL] [Abstract][Full Text] [Related]
18. Role of GPX4 in ferroptosis and its pharmacological implication.
Seibt TM; Proneth B; Conrad M
Free Radic Biol Med; 2019 Mar; 133():144-152. PubMed ID: 30219704
[TBL] [Abstract][Full Text] [Related]
19. Ferroptotic cell death triggered by conjugated linolenic acids is mediated by ACSL1.
Beatty A; Singh T; Tyurina YY; Tyurin VA; Samovich S; Nicolas E; Maslar K; Zhou Y; Cai KQ; Tan Y; Doll S; Conrad M; Subramanian A; Bayır H; Kagan VE; Rennefahrt U; Peterson JR
Nat Commun; 2021 Apr; 12(1):2244. PubMed ID: 33854057
[TBL] [Abstract][Full Text] [Related]
20. Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence.
Luis G; Godfroid A; Nishiumi S; Cimino J; Blacher S; Maquoi E; Wery C; Collignon A; Longuespée R; Montero-Ruiz L; Dassoul I; Maloujahmoum N; Pottier C; Mazzucchelli G; Depauw E; Bellahcène A; Yoshida M; Noel A; Sounni NE
Redox Biol; 2021 Jul; 43():102006. PubMed ID: 34030117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
